AI assistant
Sending…
PDS Biotechnology Corp — Director's Dealing 2019
Mar 26, 2019
34613_dirs_2019-03-25_86aab39b-f243-4065-80a1-f748a2d0b0b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2019-03-15
Reporting Person: SYKES RICHARD (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 60493 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.87 | 2024-12-15 | Common Stock (26474) | Direct |
Footnotes
F1: Stock Option fully vested pursuant to its terms.
More from PDS Biotechnology Corp
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 1
Registration Form
2026
Apr 27
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3